Leslie Randall - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by Leslie Randall

This paper is made freely available by the publisher.

2023 Ignace Vergote

ORCID

, Els Van Nieuwenhuysen, Roisin E. O'Cearbhaill

ORCID

, Anneke Westermann

ORCID

, Domenica Lorusso

ORCID

, Sharad Ghamande, Dearbhaile C. Collins

ORCID

, Susana Banerjee

ORCID

, Cara A. Mathews

ORCID

, Christine Gennigens, David Cibula

ORCID

, Krishnansu S. Tewari

ORCID

, Kristine Madsen, Fatih Köse, Amanda L. Jackson and 16 other authors

Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study

Download from doi.org

This paper is made freely available by the publisher.

2022 Benoit You

ORCID

, Christopher Purdy, Larry J. Copeland

ORCID

, Elizabeth M. Swisher, Michael A. Bookman

ORCID

ORCID

, Robert Coleman

ORCID

, Leslie M. Randall

ORCID

, Krishnansu S. Tewari

ORCID

, Bradley J. Monk

ORCID

, Robert S. Mannel, Joan L. Walker

ORCID

, Fabio Cappuccini, David Cohn

ORCID

, Mahvish Muzaffar

ORCID

and 5 other authors

Identification of Patients With Ovarian Cancer Experiencing the Highest Benefit From Bevacizumab in the First-Line Setting on the Basis of Their Tumor-Intrinsic Chemosensitivity (KELIM): The GOG-0218 Validation Study

Download from doi.org

Missing publications? Search for publications with a matching author name.